<DOC>
	<DOCNO>NCT02953379</DOCNO>
	<brief_summary>The purpose study evaluate non-inferiority clinical efficacy mometasone nasal gel treatment allergic rhinitis .</brief_summary>
	<brief_title>Efficacy Safety Mometasone Nasal Gel Treatment Persistent Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Signed Consent patient ; Clinical diagnosis moderate severe persistent allergic rhinitis accord ARIA classification ( Allergic Rhinitis Its Impact Asthma ) ; Patients clinically significant disease investigator opinion ´t participate study ; Patients laboratory find image find investigator opinion can´t participate clinical trial ; Patients history hypersensitivity formula compound ; Participation clinical trial year prior study ; Pregnancy risk pregnancy lactate patient ; Patients use drug interfere evaluation ; Decongestants dependent patient patient receive allergen specific immunotherapy ; Patients treatment monoamine oxidase inhibitor ( MAOIs ) ; History hypertension , coronary artery disease , cardiac arrhythmia , glaucoma , hyperthyroidism / prostatic hypertrophy .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>